VIIP International Congress - September 18th-20th | 2024

VIIP – Viral Infections in Immunocompromised Patients – International Congress has been created in 2010 from an idea of Prof. Paolo Grossi. After four residential editions and one online edition due to the covid-19 pandemic, it’s become time for the VIIP Congress to renew itself.

The residential congress, hosted in the city of Varese – Italy. Moreover with the creation of this site the VIIP Congress aims to became a community of helthcare professionals who are interested in the clinical aspects of viral infectious diseases in immunocompromised patients.

VIIP Congress during the years, and thanks to an exceptional international faculty of clinical experts, has established itself as one of the most comprehensive  meetings on viral infections in immunocompromised patients. Starting from now all this knowledge will be made freely available to anyone.


All time is expressed in CEST (UTC +2)


Paolo Grossi MD, PhD

Paolo Grossi is Professor of Infectious Diseases at the University of Insubria in Varese, Italy. He is also the Director of the Infectious and Tropical Diseases Department of the Ospedale di Circolo and Fondazione Macchi of Varese, Italy, and the Director of the Department of Transplantation. He is a member of the steering committee of the ESCMID Study Group on infections in Immunocompromised Host (ESGICH). The main research interest is in the field of infectious complications in transplant recipients. He is author or co-author of more than 200 publications in the field of infectious disease in immunocompromised patients.



September 18th-20th, 2024


Palace Grand Hotel Via Luciano Manara 11 – Varese, ITALY


For all inquiries regarding registration please contact the Organizing Secretariat


Solid organ and hematopoietic stem cell transplantation practice has improved tremendously in the last few decades, and it has overcome major technical limitations to become the success it is today.

Currently, transplant practice is considered a clinical routine, lifesaving, reliable and cost-effective activity, when compared to alternative treatments on onco-hematology field as well as those for end-stage organ diseases, both acute and chronic conditions.

Moreover, recent advances in transplant activity have shed light on the management of patients with viral infections (hepatitis B, C and D virus, HIV and respiratory viruses), thanks also to the recent introduction of new antiviral drugs and the upcoming availability of cell-based therapies.

However, infectious complications that can occur on post-transplant period are complex and represent a constantly evolving issue: that’s why healthcare professionals need continuous updating to be able to always ensure patients a high standard of care.

Since its first edition held in 2010, the mission of International Congress “Viral Infections in Immunocompromised Patients”, born from a brilliant idea of Professor Paolo Grossi, is to give attendees a unique opportunity to deepen and rise knowledge related to transplantation, through a wide and up to date scientific program, led by best clinical experts on this field.





Thanks to the following companies for their unconditional support:

MSD – Pfizer – Pierre Fabre

Grifols – Shionogi

Elitech – Chiesi